Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Western Ontario

$24,948.00

Evaluation of high-resolution ultrasound imaging methods for quantification of tumour volume and vascularization

FY 2012-13

Summary
The aggressive nature of cancer requires treatments that simultaneously deliver multiple blows to a tumour. Animal models of human cancers are used to understand the action of new anti-cancer treatments and assess their safety for use in human patients. However, the majority of studies using animal models rely on a limited number of measurements that typically only assess the treatment's effect on tumour growth. Other physiological parameters that can shed light on a treatment's effectiveness can usually only be measured upon sacrifice of the research animals. Armour Therapeutics Inc. is developing novel treatments for breast and prostate cancers that attack tumours through several different mechanisms. Armour is therefore in need of methods to evaluate each of these mechanisms in live animal models. This need can be met by biomedical imaging technologies that measure multiple biological parameters in intact tumours. This research collaboration will analyze and validate high-resolution three-dimensional ultrasound imaging techniques designed for studying mouse models of cancer, with an emphasis on methods for determining the effects of a treatment on a tumour's blood supply. We will compare multiple ultrasound-based methods for measuring tumour blood flow and determine which method can most accurately be used in place of labour-intensive analyses of tumour pathology specimens. The results of the project will enable Armour to make an informed decision about the utility of ultrasound imaging for future drug discovery and characterization studies. The availability of a fast, economical method for measuring blood flow in live tumour models will accelerate Armour's drug development process, thereby greatly reducing the number of research animals sacrificed and helping to make new therapies available to cancer patients more quickly.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
430477-2012
Name nom
Lacefield, James
Department département
Electrical and Computer Engineering
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
24948
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Evaluation of high-resolution ultrasound imaging methods for quantification of tumour volume and vascularization
Keyword
NSERC
Application summary
The aggressive nature of cancer requires treatments that simultaneously deliver multiple blows to a tumour. Animal models of human cancers are used to understand the action of new anti-cancer treatments and assess their safety for use in human patients. However, the majority of studies using animal models rely on a limited number of measurements that typically only assess the treatment's effect on tumour growth. Other physiological parameters that can shed light on a treatment's effectiveness can usually only be measured upon sacrifice of the research animals. Armour Therapeutics Inc. is developing novel treatments for breast and prostate cancers that attack tumours through several different mechanisms. Armour is therefore in need of methods to evaluate each of these mechanisms in live animal models. This need can be met by biomedical imaging technologies that measure multiple biological parameters in intact tumours. This research collaboration will analyze and validate high-resolution three-dimensional ultrasound imaging techniques designed for studying mouse models of cancer, with an emphasis on methods for determining the effects of a treatment on a tumour's blood supply. We will compare multiple ultrasound-based methods for measuring tumour blood flow and determine which method can most accurately be used in place of labour-intensive analyses of tumour pathology specimens. The results of the project will enable Armour to make an informed decision about the utility of ultrasound imaging for future drug discovery and characterization studies. The availability of a fast, economical method for measuring blood flow in live tumour models will accelerate Armour's drug development process, thereby greatly reducing the number of research animals sacrificed and helping to make new therapies available to cancer patients more quickly.
University of Western Ontario - $24,948 Grant (2012-1… | Canada Spends